Long-term study of fluvoxamine: a new rapid-acting antidepressant.
This was a 1-year study of fluvoxamine in 31 depressed male and female patients with a history of chronic recurring depression of various types. Fluvoxamine has a rapid action with lifting of the mood often within 4-7 days, in a dosage range from 150 to 200 mg/day. Suicidal ideation in 8 patients disappeared within 5-6 days. There were few side effects. This new antidepressant seemed to be very effective especially in endogenous depression.
D000328:Adult; D000368:Aged; D000928:Antidepressive Agents / Q000627:therapeutic use*; D003866:Depressive Disorder / Q000188:drug therapy* / Q000523:psychology; D005260:Female; D016666:Fluvoxamine; D006801:Humans; D008297:Male; D008875:Middle Aged; D010091:Oximes / Q000627:therapeutic use*; D011569:Psychiatric Status Rating Scales; D012008:Recurrence
D000928:Antidepressive Agents; D010091:Oximes; D016666:Fluvoxamine